Clinical Trial

Energy CT in Imaging and Diagnosis of Gastric Cancer

Study acronym: CTIDGC
Recruiting
View on ClinicalTrials.gov →
Summary
Accurate preoperative prediction of risk stratification, treatment response, and survival prognosis in gastric cancer is important for improving clinical treatment decisions, prolonging patient survival, and improving patient quality of life. The purpose of this study is to investigate the performance of the multi-parametric magnetic resonance imaging (mpMRI) and Dual-/Muti-energy CT and photon-counting Detector CT(PCD-CT) in the diagnosis and management of gastric cancer.
Trial Details
NCT Number NCT06869694
Lead Sponsor The First Affiliated Hospital of Zhengzhou University
Conditions Gastric Cancer, CT
Enrollment 300 participants
Start Date 2024-09-01
Primary Completion 2026-09-01 (estimated)
Study Completion 2028-09-01 (estimated)
Updated on ClinicalTrials.gov 2025-03-11